Navigation Links
Burzynski Clinic Announces the Response to the Allegations and Complaint by the Texas Medical Board Against Dr. Burzynski
Date:1/8/2014

HOUSTON, Jan. 8, 2014 /PRNewswire/ -- The Burzynski Clinic (BC) announced today the preliminary response to the allegations in the lawsuit filed by Texas Medical Board (TMB) at the Texas State Office of Administrative Hearing on December 11, 2013 against Stanislaw R. Burzynski, M.D., Ph.D. (SRB).  The allegations claim that SRB used internet-based advertising regarding antineoplastons (ANP), and that it was false, misleading, and violated federal law.  The allegations can be divided into concerning preclinical and clinical research.  The TMB claims that the terms used by SRB for the description of the mechanism of action of ANP, such as, molecular switches that cause the death of cancer cells, but do not inhibit normal cells and that ANP are multitargeted agents, are false and misleading.  These terms were introduced in numerous publications in peer-reviewed journals and presentations at medical meetings by SRB and outside researchers, and represent findings of medical research permitted by Federal Law.

In the area of clinical research, the TMB claims the false statement that ANP treatment is limited to patients who cannot be helped by other treatments and have the worst type of cancer.  This true statement is derived from FDA supervised protocols, which restrict ANP to only such cases.  The TMB further claims that the information that 50% of children under 3 years survive over 5 years and that the clinic has patients who survived over 20 years without any sign of cancer, is false.  These statements are true and supported by data coming from clinical trials which were published in peer-reviewed journals and presented at medical meetings.  In fact, the percentage of survival at 5 years of children in this age group is 57% and currently there are 11 patients diagnosed with incurable cancer who are surviving over 20 years as a result of treatment with ANP. 
'/>"/>

SOURCE Burzynski Clinic
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Burzynski Clinic Presents the Results of Phase II Study of Antineoplastons in Children with Recurrent High-Grade Glioma at the Congress
2. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
3. Positive Clinical Study Results for BSPs HyperQ Technology
4. DermTechs Non-invasive Melanoma Detection Assay Poised to Enter Clinical Validation Study
5. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
6. AtheroNova Inc. Preclinical Study Demonstrates 95% Reduction in Arterial Plaque Formation
7. A New Type of Dendritic Cell-Based Cancer Vaccine has Received Approval for Clinical Tests and at the Same Time Secures Substantial Financing
8. Generex Provides Update on Generex Oral-lyn™ Clinical & Regulatory Program
9. US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium
10. TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML)
11. Echo Therapeutics Announces Positive Results of Clinical Trial of its Symphony® Transdermal Continuous Glucose Monitoring (tCGM) System in Patients With Type 1 and Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... , Jan. 22, 2015   Cypher Genomics, Inc., ... Inc. (NASDAQ: SQNM ), the leading ... for next generation noninvasive prenatal tests (NIPT). Through ... technology, called Mantis™, to advance analysis of clinically-relevant ...
(Date:1/22/2015)... , Jan. 22, 2015  Derma Sciences, Inc. ... company focused on advanced wound care, announces that ... tissues, have been added to the Premier, Inc. ... the opportunity for the AMNIOEXCEL® and AMNIOMATRIX® product ...
(Date:12/24/2014)... , Dec. 24, 2014 PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: PTBI, ... announced the closing of an underwritten public offering of 3,500,000 ... an aggregate 3,500,000 shares of common stock, at an offering ... warrants have a per share exercise price of $5.00, are ...
(Date:12/24/2014)... 2014 “Preparative & Process Chromatography ... Consumables (Columns, Solvents, Buffers, Valves, Guages, Seals), Accessories, ... - Forecasts to 2019” provides a detailed overview ... market trends, and strategies impacting the preparative and ...
Breaking Biology Technology:Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4
... Wis. Wisconsin businesses and individuals are invited ... Products Awards Competition, which recognizes benefits coming from ... technologies. , ,Governor's New Products Awards are ... or more employees); large companies (500-999 employees); medium ...
... latest business venture of Mike Strand in Eau Claire ... competition, has landed $250,000 from the Chippewa Valley ... has a plan to put video screens showing advertising ... the statewide business-plan competition finals, it won the emerging ...
... Wis. — Sonic Foundry posted mixed financial numbers for ... while still posting a net loss. , ,Revenues were $8.3 ... with unit sales up 74 percent, owing to multiple unit ... , ,Operating expenses increased by 20 percent, however, and the ...
Cached Biology Technology:
(Date:12/22/2014)... 2014  NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) ... the growing mobile commerce market, announces it has retained famous ... the 2015 International CES debut of the Wocket™ biometric smart ... at the NXT-ID booth January 6th and 7 th , ...
(Date:12/22/2014)... 2014 Holiday Season may be the brightest ever for ... the long anticipated floodgates for consumer biometrics may finally ... phones, tablets, and wearable mobile devices that incorporate biometrics ... with nearly 4.8 billion biometric devices by 2020.   ...
(Date:12/19/2014)... Research and Markets ( http://www.researchandmarkets.com/research/86ncd6/micro_market ) has announced ... Perimeter Security Systems Market" report to their offering. ... American perimeter security market is estimated to grow at a ... market holds a larger share in this market, ...
Breaking Biology News(10 mins):NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 4First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3
... a detailed picture of how and when opsins evolved, ... including humans. The evolutionary origins of vision remain ... relationships among the earliest opsin-possessing animals. Dr Davide ... at NUI Maynooth performed a computational analysis to test ...
... scattering experiments have provided new insights into the origin ... all over the world. The analysis conducted by scientists ... Grenoble, and published in Scientific Reports , follows ... reduce these harmful complications. Wherever you are in ...
... in Toronto have established that a drug recently approved ... a rare form of cystic fibrosis works in an ... various forms of cystic fibrosis. Cystic fibrosis is ... world. Cystic fibrosis patients carry a defective gene that ...
Cached Biology News:Neutrons help explain why antibiotics prescribed for chemotherapy cause kidney failure 2Neutrons help explain why antibiotics prescribed for chemotherapy cause kidney failure 3Neutrons help explain why antibiotics prescribed for chemotherapy cause kidney failure 4Insights into a new therapy for a rare form of cystic fibrosis 2
... weight determinations for petroleum-based applications. Multiple solvents can be used, such as water, benzene, formamide, ... ... ... ...
rat Leptin...
SHEEP ANTI ESCHERICHIA COLI...
... culture chambered coverslips are convenient ... staining and imaging. The chambered ... with standard optical-quality coverslips and ... to use. Preassembled CultureWell systems ...
Biology Products: